Celldex Therapeutics reported $-73.62M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
AbbVie USD 5.72B 69M Jun/2025
Amgen USD 4.43B 2.17B Sep/2025
Bristol-Myers Squibb USD 4.04B 1.78B Sep/2025
Celldex Therapeutics USD -73.62M 9.76M Sep/2025
Glaxosmithkline GBP 3.76B 1.69B Sep/2025
Pfizer USD 4.57B 1.97B Sep/2025
Roche Holding CHF 9.56B 2.1B Dec/2025